ALPHARETTA, Ga.--(BUSINESS WIRE)--Cartiva, Inc. (Company), a developer of innovative solutions for the treatment of cartilage damage and osteoarthritis, today announced the publication of a peer-reviewed article entitled “First metacarpal resurfacing with polyvinyl alcohol implant in rhizarthrosis: Preliminary study.” The study, which was published in the June 2014 issue of Chirurgie de la Main, demonstrated significant clinical improvement using Cartiva Synthetic Cartilage Implant (SCI) in patients with osteoarthritis of the first carpometacarpal (CMC) joint at the base of the thumb. Cartiva SCI is a proprietary polyvinyl alcohol (PVA) hydrogel that was designed to mimic natural cartilage.
Help employers find you! Check out all the jobs and post your resume.